The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

Simvastatin is among the most commonly used prescription medications for cholesterol reduction. A single coding single-nucleotide polymorphism, rs4149056T>C, in SLCO1B1 increases systemic exposure to simvastatin and the risk of muscle toxicity. We summarize evidence from the literature supporting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ramsey, L B, Johnson, S G, Caudle, K E, Haidar, C E, Voora, D, Wilke, R A, Maxwell, W D, McLeod, H L, Krauss, R M, Roden, D M, Feng, Q, Cooper-DeHoff, R M, Gong, L, Klein, T E, Wadelius, M, Niemi, M
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2014
Materias:
CPIC Update
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169720/
https://ncbi.nlm.nih.gov/pubmed/24918167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.125
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares